Dr. Aseem Malhotra

And I used, of course, the heart disease paradigm to understand why we hadn't curbed heart disease, even though it was predicted by Nobel Prize winners Brown and Goldstein, I think, in the late 90s, who discovered the LDL receptor was involved in coronary artery disease. They predicted the end. the eradication of heart disease may completely end by the early 2000s. Didn't happen.

And I used, of course, the heart disease paradigm to understand why we hadn't curbed heart disease, even though it was predicted by Nobel Prize winners Brown and Goldstein, I think, in the late 90s, who discovered the LDL receptor was involved in coronary artery disease. They predicted the end. the eradication of heart disease may completely end by the early 2000s. Didn't happen.

And I used, of course, the heart disease paradigm to understand why we hadn't curbed heart disease, even though it was predicted by Nobel Prize winners Brown and Goldstein, I think, in the late 90s, who discovered the LDL receptor was involved in coronary artery disease. They predicted the end. the eradication of heart disease may completely end by the early 2000s. Didn't happen.

It's still the number one killer on the planet. Exactly, despite a mass prescription of statins.

It's still the number one killer on the planet. Exactly, despite a mass prescription of statins.

It's still the number one killer on the planet. Exactly, despite a mass prescription of statins.

Three reasons I can tell you, big low-hanging fruit, why have we got less death rates from heart disease? If you were a smoker, your mortality rate increased 50%. Smoking reductions played a big role.

Three reasons I can tell you, big low-hanging fruit, why have we got less death rates from heart disease? If you were a smoker, your mortality rate increased 50%. Smoking reductions played a big role.

Three reasons I can tell you, big low-hanging fruit, why have we got less death rates from heart disease? If you were a smoker, your mortality rate increased 50%. Smoking reductions played a big role.

emergency treatment in specifically in the acute setting of an acute heart attack stenting or thrombolytics which we used to use blood clot busters but the third one which the Bernard Lowne pioneering cardiologist got the Nobel Prize for was the defibrillator

emergency treatment in specifically in the acute setting of an acute heart attack stenting or thrombolytics which we used to use blood clot busters but the third one which the Bernard Lowne pioneering cardiologist got the Nobel Prize for was the defibrillator

emergency treatment in specifically in the acute setting of an acute heart attack stenting or thrombolytics which we used to use blood clot busters but the third one which the Bernard Lowne pioneering cardiologist got the Nobel Prize for was the defibrillator

So what used to happen is patients would be admitted to hospital with a heart attack, and the first 24 to 48 hours after having a heart attack, you're most vulnerable to having a cardiac arrhythmia that causes you to have a cardiac arrest, and patients would die. They could develop cardiac anus. So we're better at saving people after they've had a problem.

So what used to happen is patients would be admitted to hospital with a heart attack, and the first 24 to 48 hours after having a heart attack, you're most vulnerable to having a cardiac arrhythmia that causes you to have a cardiac arrest, and patients would die. They could develop cardiac anus. So we're better at saving people after they've had a problem.

So what used to happen is patients would be admitted to hospital with a heart attack, and the first 24 to 48 hours after having a heart attack, you're most vulnerable to having a cardiac arrhythmia that causes you to have a cardiac arrest, and patients would die. They could develop cardiac anus. So we're better at saving people after they've had a problem.

Well, so the next question is people think, oh, it must be statins as well. Well, a paper in the BMJ a few years ago looked at millions more people taking statins in Europe over a 10-year period to see was there any reduction in cardiovascular mortality in Europe because millions more people were taking statins. And they found there was none, none, zero, no change.

Well, so the next question is people think, oh, it must be statins as well. Well, a paper in the BMJ a few years ago looked at millions more people taking statins in Europe over a 10-year period to see was there any reduction in cardiovascular mortality in Europe because millions more people were taking statins. And they found there was none, none, zero, no change.

Well, so the next question is people think, oh, it must be statins as well. Well, a paper in the BMJ a few years ago looked at millions more people taking statins in Europe over a 10-year period to see was there any reduction in cardiovascular mortality in Europe because millions more people were taking statins. And they found there was none, none, zero, no change.

how you can actually explain that mark because one way of looking at the statistics looking at industry sponsored trials which we've already alluded to should be taken with a grain of salt because they are best case scenario they're curated information or a tab of butter maybe well yeah actually absolutely butter would be better remind me to come back about a butter story and me being hauled into a medical director's office to talk about butter by the way um when i busted the myth of saturated fat and heart disease you know when you look at the data

how you can actually explain that mark because one way of looking at the statistics looking at industry sponsored trials which we've already alluded to should be taken with a grain of salt because they are best case scenario they're curated information or a tab of butter maybe well yeah actually absolutely butter would be better remind me to come back about a butter story and me being hauled into a medical director's office to talk about butter by the way um when i busted the myth of saturated fat and heart disease you know when you look at the data